Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


The Dutch question: should customs detain generics in transit?

This article was originally published in Scrip

Executive Summary

The detention of generic drug shipments by the Dutch customs authorities has caused something of a furore, and one that seems likely to rage for some time. A solution is urgently needed, but the problem is that no-one – including the Dutch government itself - seems to know exactly what is going on.

You may also be interested in...

UK Presents New Licensing Pathway For Innovative Drugs

A “powerful new vision” for the post-Brexit UK regulatory framework was unveiled at a conference organized by the BioIndustry Association and the medicines regulator, the MHRA.

Coronavirus Notebook: EU Invests In Convalescent Plasma, ACT-Accelerator Wants More Vaccines

InflaRx and Relief Therapeutics/NeuroRx are investigating potential new treatments for COVID-19-induced pneumonia and for coronavirus-related ARDS.

Coronavirus Notebook: UK To Test Inhaled Vaccines & Regeneron’s Antibody Cocktail

The UK government has also entered into a supply deal with French firm Valneva for 60 million doses of its inactivated COVID-19 vaccine, VLA2001.





Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts